Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6751
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$82.7M
| $957K | ﹤0.01% |
42,498
+9,749
| +30% | +$205K |
|
6752
PUT
Bank OZK
OZK
$5.72B
| $957K | ﹤0.01% |
30,600
-45,200
| -60% | -$1.22M |
|
6753
CALL
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.38B
| $957K | ﹤0.01% |
+3
| New | +$1.58M |
|
6754
iShares US Insurance ETF
IAK
$539M
| $956K | ﹤0.01% |
14,156
-20,167
| -59% | -$1.26M |
|
6755
PUT
Commercial Metals
CMC
$7.92B
| $955K | ﹤0.01% |
+46,500
| New | +$965K |
|
6756
InfuSystem Holdings
INFU
$244M
| $955K | ﹤0.01% |
50,883
+2,912
| +6% | +$43.9K |
|
|
NOAH
6757
Noah Holdings
NOAH
$592M
| $955K | ﹤0.01% |
19,973
-33,256
| -62% | -$1.07M |
|
6758
CALL
Stem
STEM
$61M
| $955K | ﹤0.01% |
+2,335
| New | +$588K |
|
|
TPIC
6759
PUT
DELISTED
TPI Composites
TPIC
| $955K | ﹤0.01% |
+18,100
| New | +$724K |
|
|
EQC
6760
PUT
DELISTED
Equity Commonwealth
EQC
| $955K | ﹤0.01% |
35,000
-2,000
| -5% | -$53.4K |
|
|
NS
6761
CALL
DELISTED
NuStar Energy L.P.
NS
| $955K | ﹤0.01% |
66,300
+45,700
| +222% | +$585K |
|
6762
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$167M
| $954K | ﹤0.01% |
10,200
-7,900
| -44% | -$592K |
|
6763
CALL
Frontdoor
FTDR
$5.96B
| $954K | ﹤0.01% |
19,000
-7,500
| -28% | -$343K |
|
6764
CALL
Southwest Gas
SWX
$6.71B
| $954K | ﹤0.01% |
15,700
+500
| +3% | +$32.9K |
|
6765
Organogenesis Holdings
ORGO
$230M
| $953K | ﹤0.01% |
+126,543
| New | +$601K |
|
|
GTHX
6766
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $953K | ﹤0.01% |
+53,000
| New | +$792K |
|
6767
PUT
Fortune Brands Innovations
FBIN
$5.71B
| $951K | ﹤0.01% |
12,987
-3,393
| -21% | -$247K |
|
6768
PUT
Worthington Enterprises
WOR
$2.87B
| $950K | ﹤0.01% |
30,007
-11,516
| -28% | -$359K |
|
6769
PUT
W.R. Berkley
WRB
$26.2B
| $950K | ﹤0.01% |
32,175
+1,125
| +4% | +$32.4K |
|
6770
Taysha Gene Therapies
TSHA
$1.94B
| $949K | ﹤0.01% |
35,752
-209,282
| -85% | -$4.51M |
|
6771
PUT
Cedar Fair
FUN
$1.68B
| $948K | ﹤0.01% |
24,100
+7,300
| +43% | +$243K |
|
6772
CALL
Genmab
GMAB
$19.6B
| $947K | ﹤0.01% |
23,300
+1,300
| +6% | +$48.6K |
|
6773
PUT
Oshkosh
OSK
$9.44B
| $947K | ﹤0.01% |
11,000
-23,600
| -68% | -$1.88M |
|
6774
Dime Commercial Bancshares
DCOM
$1.81B
| $946K | ﹤0.01% |
39,145
-489
| -1% | -$10.6K |
|
6775
NVE Corp
NVEC
$587M
| $946K | ﹤0.01% |
16,850
-5,296
| -24% | -$272K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.